deal
LegoChem and Iksuda expand License Agreement for antibody drug conjugates
June 22, 2021Manufacturing and Production ADC, License Agreement, deal, technology
Iksuda Therapeutics, a developer of antibody drug conjugates (ADCs), has announced the expansion of the research collaboration and License Agreement …
Novo Holdings acquires BBI Group in £400 million deal
June 15, 2021Manufacturing and Production acqusition, deal, finance
Novo Holdings, a holding company of the Novo Group, has acquired BBI Group from Exponent for an enterprise value of …
MSD partners up with Seattle Genetics in two oncology development deals potentially worth over $4bn
September 15, 2020Manufacturing and Production, Sales and Marketing MSD, Seattle Genetics, deal, pharma
MSD has signed two new oncology-based deals with Seattle Genetics which together could be worth up to around $4.4 billion. …
Amgen drops $2.7bn to acquire stake in Chinese biotech in bid to expand in the region
November 1, 2019Medical Communications, Research and Development, Sales and Marketing Amgen, BeiGene, Cancer, China, deal, oncology, pharma
Amgen has signed an agreement with Chinese biotech BeiGene to acquire a 20.5% stake in the latter, in a bid …
Gilead buys Novartis’ herpes, flu and cold virus preclinical programmes
July 23, 2019Manufacturing and Production Gilead, Novartis, antivrial, deal, herpes, influenza, rhinovirus
Gilead has acquired the rights to three of Novartis’ preclinical antiviral programmes, including investigational compounds with the potential to treat …
Gilead invests $5.1 billion into Galapagos NV
July 15, 2019Sales and Marketing Galapagos, Gilead, biotech, collaboration, deal, drug discovery, pharma
Gilead has entered into a 10 year partnership with Belgo-Dutch biotech Galapagos NV. The collaboration will see Gilead invest $5.1 …
MSD buys Peloton Therapeutics in deal worth $2.1 billion
May 22, 2019Research and Development Cancer, MSD, acquisition, biotech, deal, oncology, pharma
MSD has agreed to acquire all outstanding shares in Peloton Therapeutics in a deal worth up to $2.1 billion. US …
Takeda completes Shire acquisition
January 8, 2019Manufacturing and Production M&A, MA, Shire, Takeda, acquisition, deal, pharma
Japanese firm Takeda Pharmaceuticals has successfully completed its acquisition of Shire Plc. The long anticipated deal has propelled the firm …
Taisho Pharma to buy Bristol-Myers Squibb’s consumer health business in deal worth $1.6 bn
December 19, 2018Business Services BMS, Japan, M&A, MA, Taisho, deal
Japanese company Taisho Pharmaceuticals has offered Bristol-Myers Squibb $1.6 billion for its UPSA consumer health business. With more than a …
Tech platform company WuXi Biologics inks deal with cancer specialist Oxford BioTherapeutics worth $450m
December 12, 2018Research and Development Cancer, Oxford Biotherapeutics, WuXi Biologics, alliance, deal, oncology
Clinical stage oncology firm Oxford BioTherapeutics has signed a deal with the open-access biologics technology platform company WuXi Biologics, in …
Boehringer signs $300 million deal with Epizyme over epigenetic cancer treatment
November 16, 2018Medical Communications Boehringer, Cancer, Epizyme, deal, oncology
German firm Boehringer Ingelheim and the Massachusetts-based biotech Epizyme have announced that they will collaborate on the development of novel, …
AstraZeneca sells off three drugs in deal worth $350 million
November 6, 2018Manufacturing and Production AstraZeneca, asthma, covis, deal, royalties
Anglo-Swedish multinational AstraZeneca has agreed to sell the rights to three asthma and rhinitis drugs in a deal worth $350 …
J&J buy global rights to Yuhan’s lazertinib in deal worth $1.2bn
November 6, 2018Manufacturing and Production J&J, JJ, NSCLC, Yuhan, deal, lazertinib, south korea
Johnson & Johnson’s Janssen Biotech unit has bought the rights to Yuhan’s third-generation EGFR tyrosine kinase inhibitor (TKI) lazertinib in a deal …
Roche signs $1 billion deal with cell therapy firm SQZ biotech
October 17, 2018Research and Development Roche, SQZ, collaboration, deal, oncology
The Massachusetts-based cell therapy company SQZ Biotech, has announced the expansion of its collaboration with Swiss pharma giant Roche, in …
Latest content
FibroFind appoints Lee Borthwick as CEO
